Skip to content
Sign in

LMAT · NASDAQ

LeMaitre Vascular (LMAT) Stock Price & Fundamentals

$486.00−1.17%−$5.76End-of-day price as of Oct 9, 2026

LeMaitre Vascular (LMAT) closed at $486.00 on Oct 9, 2026, down 1.17% from the previous close of $491.76.

Share price, past year

1Y +23.12%

52-week range $370.51 – $495.90. Daily closing prices.
Monthly closing prices
Last closing price of each month
DateClose
Oct 9, 2026$486.00
Sep 30, 2026$486.37
Aug 31, 2026$436.80
Jul 31, 2026$441.28
Jun 30, 2026$412.62
May 29, 2026$430.67
Apr 30, 2026$432.62
Mar 31, 2026$413.33
Feb 27, 2026$387.52
Jan 30, 2026$386.23
Dec 31, 2025$407.58
Nov 28, 2025$401.28
Oct 31, 2025$400.39

Key statistics

Market cap
$11.11B
P/E (TTM)
169.9
EPS (TTM)
$2.86
Revenue (TTM)
$262.43M
Net income (TTM)
$65.67M
Shares outstanding
22.9M
Dividend yield
0.19%
52-week range
$370.51 – $495.90

LeMaitre Vascular's market cap is $11.11B, based on a share price of $486.00 and 22.9M shares outstanding as of Jun 30, 2026.

Financials

LeMaitre Vascular reported revenue of $249.60M for fiscal 2025, up 13.53% from fiscal 2024.

LeMaitre Vascular earned net income of $57.73M in fiscal 2025, a net margin of 23.1%.

Fiscal 2025 revenue was the highest in the 10 years shown.

Annual revenue

FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25
Annual revenue by fiscal year; the table below lists the values.
LeMaitre Vascular annual financials by fiscal year, from SEC filings
Fiscal yearRevenueGrowthNet incomeNet marginEPS (diluted)Free cash flow
FY2025ended Dec 31, 2025$249.60M+13.5%$57.73M23.1%$2.52—
FY2024ended Dec 31, 2024$219.86M+13.6%$44.04M20.0%$1.93—
FY2023ended Dec 31, 2023$193.48M+19.7%$30.11M15.6%$1.34—
FY2022ended Dec 31, 2022$161.65M+4.7%$20.64M12.8%$0.93—
FY2021ended Dec 31, 2021$154.42M+19.4%$26.91M17.4%$1.25—
FY2020ended Dec 31, 2020$129.37M+10.4%$21.22M16.4%$1.04—
FY2019ended Dec 31, 2019$117.23M+11.1%$17.93M15.3%$0.88—
FY2018ended Dec 31, 2018$105.57M+4.7%$22.94M21.7%$1.13—
FY2017ended Dec 31, 2017$100.87M+13.1%$17.18M17.0%$0.86—
FY2016ended Dec 31, 2016$89.15M—$10.59M11.9%$0.55$14.06M
LeMaitre Vascular quarterly results
QuarterRevenueNet incomeEPS (diluted)
Q2 FY2026ended Jun 30, 2026$70.38M$17.05M$0.74
Q1 FY2026ended Mar 31, 2026$66.55M$15.68M$0.68
Q4 FY2025ended Dec 31, 2025$64.45M$15.58M$0.69
Q3 FY2025ended Sep 30, 2025$61.05M$17.36M$0.75
Q2 FY2025ended Jun 30, 2025$64.23M$13.78M$0.60
Q1 FY2025ended Mar 31, 2025$59.87M$11.01M$0.48
Q4 FY2024ended Dec 31, 2024$55.72M$11.18M$0.48
Q3 FY2024ended Sep 30, 2024$54.82M$11.14M$0.49

Company profile

Name
LeMaitre Vascular, Inc.
Ticker
LMAT
Exchange
NASDAQ
Industry (SEC SIC)
Surgical & Medical Instruments & Apparatus
Headquarters
63 Second Avenue, Burlington, MA 01803
Fiscal year ends
December
SEC CIK
0001158895

Recent SEC filings

Frequently asked questions

What is LeMaitre Vascular's stock price?

LeMaitre Vascular (LMAT) closed at $486.00 on Oct 9, 2026, down 1.17% from the previous close of $491.76.

What is LeMaitre Vascular's market cap?

LeMaitre Vascular's market cap is $11.11B, based on a share price of $486.00 and 22.9M shares outstanding as of Jun 30, 2026.

How much revenue does LeMaitre Vascular make?

LeMaitre Vascular reported revenue of $249.60M for fiscal 2025, up 13.53% from fiscal 2024.

What is LMAT's P/E ratio?

LeMaitre Vascular's price-to-earnings ratio is 169.9, based on trailing twelve-month diluted EPS of $2.86.

Does LeMaitre Vascular pay a dividend?

Yes. LeMaitre Vascular declared $0.90 per share in dividends over the last four quarters, a yield of 0.19%.

Sources and methodology

Fundamentals come from LeMaitre Vascular, Inc.'s filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures